Randall D. Marshall

Chief Tech/Sci/R&D Officer at Eumentis Therapeutics, Inc.

Consumer Services

Commercial Services

Health Technology

Profile

Randall D.
Marshall is currently the Director & Chief Medical Officer at Eumentis Therapeutics, Inc. Previously, he worked as the Executive Director-Medical Affairs at Euthymics Bioscience, Inc. Marshall received his undergraduate degree from Rice University and his doctorate from The Johns Hopkins University.

Randall D. Marshall active positions

Companies	Position	Start
Eumentis Therapeutics, Inc. Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation.	Chief Tech/Sci/R&D Officer	-

All active positions of Randall D. Marshall

Former positions of Randall D. Marshall

Companies	Position	End
Euthymics Bioscience, Inc. Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-

See the detail of Randall D. Marshall's experience

Training of Randall D. Marshall

The Johns Hopkins University	Doctorate Degree
Rice University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Randall D. Marshall's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Euthymics Bioscience, Inc. Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA.	Commercial Services
Eumentis Therapeutics, Inc. Eumentis Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Eumentis Therapeutics, Inc. manufactures novel drugs. The American company was founded by Mark A. Tepper and he has been the CEO since incorporation.	Health Technology